Baxter International Inc. (BAX)
NYSE • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Baxter International Inc. keeps $4 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 29
in 49 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Baxter International beat expectations on both the top and bottom line in preliminary second fiscal quarter 2026 results reported July 30. Revenue rose about 5% to roughly $3.0 billion from $2.81 billion a year earlier, topping the $2.8 billion consensus by about 6%, with the U.S. remaining the largest region at about $1.6 billion and growing nearly 4%. Adjusted EPS was $0.56 versus the $0.37 estimate, about +53%, while gross margin held near 35% on gross profit of about $1.0 billion. On a year-over-year basis, adjusted EPS slipped about 5% from $0.59. Operating cash flow was negative $213.0 million, and the company paid $5.0 million in dividends. Consensus for the next period calls for adjusted EPS of $0.53 on revenue of $2.87 billion.
About Baxter International Inc.
Baxter International Inc. trades on the NYSE under BAX and makes a broad range of hospital and clinical-care equipment, therapies, and supplies across the healthcare sector. Its business spans dialysis treatments, IV therapies, infusion systems, surgical technologies, and critical-care products, and it generated $11.2 billion of revenue in FY2025.
Today's Snapshot
BAX opened 0.8% lower at 24.20, while its sector was flat.
Trading Volume
Below 10d avg (4.2M)
1M
vs S&P 500 Today
Inline with Market
+0.10%
Updated: September 10, 2026 at 14:35 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$21.79 - $25.54Sell
- RSI (14)36.46Neutral
- Stochastic %K (14, 3, 3)4.04Buy
- MACD Level (12, 26)-0.14Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.